Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts

Clinica Chimica Acta

Volumn 325, Issue 1-2, 2002, Pages 59-70

  Magnusson, Per ^a,b   Sharp, Christopher A ^c   Farley, John R ^b,d  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alkaline phosphatase; Biochemical markers; Bone turnover; Glycosylphosphatidylinositol specific phospholipase D; Musculoskeletal diseases; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; GLYCOSYLPHOSPHATIDYLINOSITOL; PHOSPHOLIPASE D; TRITON X 100;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BONE TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SERUM; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE AND BONES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FEMUR; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OSTEOSARCOMA; PHOSPHOLIPASE D; TISSUE DISTRIBUTION;

EID: 0036843257     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00248-6     Document Type: Article

References (49)

1. Millán J.L., Fishman W.H. Biology of human alkaline phosphatases with special reference to cancer. Crit. Rev. Clin. Lab. Sci. 32:1995;1-39.
2. Magnusson P., Degerblad M., Sääf M., Larsson L., Thorén M. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J. Bone Miner. Res. 12:1997;210-220.
3. Fedde K.N., Lane C.C., Whyte M.P. Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma cells. Arch. Biochem. Biophys. 264:1988;400-409.
4. Hooper N.M. Glycosyl-phosphatidylinositol anchored membrane enzymes. Clin. Chim. Acta. 266:1997;3-12.
5. Tenenbaum H.C. Levamisole and inorganic pyrophosphate inhibit β-glycerophosphate induced mineralization of bone formed in vitro. Bone Miner. 3:1987;13-26.
6. Bellows C.G., Aubin J.E., Heersche J.N.M. Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner. 14:1991;27-40.
7. Barling P.M., Gupta D.K., Lim C.E.L. Involvement of phosphodiesterase I in mineralization: histochemical studies using antler from red deer (Cervus elaphus) as a model. Calcif. Tissue Int. 65:1999;384-389.
8. Wennberg C., Hessle L., Lundberg P.et al. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J. Bone Miner. Res. 15:2000;1879-1888.
9. Farley J.R., Baylink D.J. Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism. 35:1986;563-571.
10. Van Straalen J.P., Sanders E., Prummel M.F., Sanders G.T.B. Bone-alkaline phosphatase as indicator of bone formation. Clin. Chim. Acta. 201:1991;27-34.
11. Fedde K.N. Human osteosarcoma cells spontaneously release matrix-vesicle-like structures with the capacity to mineralize. Bone Miner. 17:1992;145-151.
12. Anh D.J., Dimai H.P., Hall S.L., Farley J.R. Skeletal alkaline phosphatase activity is primarily released from human osteoblasts in an insoluble form, and the net release is inhibited by calcium and skeletal growth factors. Calcif. Tissue Int. 62:1998;332-340.
13. Anderson H.C. Molecular biology of matrix vesicles. Clin. Orthop. 314:1995;266-280.
14. Farley J.R., Stilt-Coffing B. Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells. Calcif. Tissue Int. 68:2001;43-52.
15. Low M.G., Carroll R.C., Cox A.C. Characterization of multiple forms of phosphoinositide-specific phospholipase C purified from human platelets. Biochem. J. 237:1986;139-145.
16. Davitz M.A., Hereld D., Shak S., Krakow J., Englund P.T., Nussenzweig V. A glycan-phosphatidylinositol-specific phospholipase D in human serum. Science. 238:1987;81-84.
17. Low M.G., Prasad A.R.S. A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc. Natl. Acad. Sci. U. S. A. 85:1988;980-984.
18. Miller J.L. Release and extracellular transit of glycosylphosphatidylinositol proteins. J. Lab. Clin. Med. 131:1998;115-123.
19. Low M.G., Huang K.-S. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Biochem. J. 279:1991;483-493.
20. Nosjean O., Briolay A., Roux B. Mammalian GPI proteins: sorting, membrane residence and functions. Biochim. Biophys. Acta. 1331:1997;153-186.
21. Rhode H., Schulze M., Cumme G.A.et al. Glycosylphosphatidylinositol-specific phospholipase D of human serum-activity modulation by naturally occurring amphiphiles. Biol. Chem. 381:2000;471-485.
22. Solter P.F., Hoffmann W.E. Solubilization of liver alkaline phosphatase isoenzyme during cholestasis in dogs. Am. J. Vet. Res. 60:1999;1010-1015.
23. Magnusson P., Löfman O., Larsson L. Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J. Chromatogr. 576:1992;79-86.
24. Magnusson P., Löfman O., Larsson L. Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography. Anal. Biochem. 211:1993;156-163.
25. Magnusson P., Häger A., Larsson L. Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr. Res. 38:1995;955-961.
26. Magnusson P., Löfman O., Toss G., Larsson L. Determination of bone alkaline phosphatase isoforms in serum by a new high-performance liquid chromatography assay in patients with metabolic bone disease. Acta Orthop. Scand. 66(Suppl. 266):1995;203-204.
27. Magnusson P., Larsson L., Englund G., Larsson B., Strang P., Selin-Sjögren L. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin. Chem. 44:1998;1621-1628.
28. Magnusson P., Larsson L., Magnusson M., Davie M.W.J., Sharp C.A. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone. J. Bone Miner. Res. 14:1999;1926-1933.
29. Jansson U.H.G., Kristiansson B., Magnusson P., Larsson L., Albertsson-Wikland K., Bjarnason R. The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease. Eur. J. Endocrinol. 144:2001;417-423.
30. Magnusson P., Sharp C.A., Magnusson M., Risteli J., Davie M.W.J., Larsson L. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int. 60:2001;257-265.
31. Radisson J., Angrand M., Chavassieux P., Roux B., Azzar G. Differential solubilization of osteoblastic alkaline phosphatase from human primary bone cell cultures. Int. J. Biochem. Cell Biol. 28:1996;421-430.
32. Bourrat C., Radisson J., Chavassieux P., Azzar G., Roux B., Meunier P.J. Activity increase after extraction of alkaline phosphatase from human osteoblastic membranes by nonionic detergents: influence of age and sex. Calcif. Tissue Int. 66:2000;22-28.
33. Nakayama M., Gorai I., Minaguchi H., Rosenquist C., Qvist P. Purification and characterization of bone-specific alkaline phosphatase from a human osteosarcoma cell line. Calcif. Tissue Int. 62:1998;67-73.
34. Huang K.-S., Li S., Fung W.-J.C.et al. Purification and characterization of glycosyl-phosphatidylinositol-specific phospholipase D. J. Biol. Chem. 265:1990;17738-17745.
35. Farley J.R., Hall S.L., Herring S., Tarbaux N.M., Matsuyama T., Wergedal J.E. Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2. Metabolism. 40:1991;664-671.
36. Farley J.R., Kyeyune-Nyombi E., Tarbaux N.M., Hall S.L., Strong D.D. Alkaline phosphatase activity from human osteosarcoma cell line SaOS-2: an isoenzyme standard for quantifying skeletal alkaline phosphatase activity in serum. Clin. Chem. 35:1989;223-229.
37. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
38. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1981;1604-1607.
39. Magnusson P., Ärlestig L., Paus E.et al. Monoclonal antibodies against tissue non-specific (liver/bone/kidney) alkaline phosphatase: the ISOBM TD-9 workshop. Tumour Biol. 23:2002;. [in press].
40. Ashwell G., Morell A.G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv. Enzymol. Relat. Areas Mol. Biol. 41:1974;99-128.
41. Ashwell G., Harford J. Carbohydrate-specific receptors of the liver. Ann. Rev. Biochem. 51:1982;531-554.
42. Meijer D.K.F., Scholtens H.B., Hardonk M.J. The role of the liver in clearance of glycoproteins from the general circulation, with special reference to intestinal alkaline phosphatase. Pharm. Weekbl., Sci. 4:1982;57-70.
43. Young G.P., Rose I.S., Cropper S., Seetharam S., Alpers D.H. Hepatic clearance of rat plasma intestinal alkaline phosphatase. Am. J. Physiol. 247:1984;G419-G426.
44. Blom E., Ali M.M., Mortensen B., Huseby N.-E. Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates. Clin. Chim. Acta. 270:1998;125-137.
45. Robinson J.C., Pierce J.E. Differential action of neuraminidase on human serum alkaline phosphatases. Nature. 204:1964;472-473.
46. Clubb J.S., Neale F.C., Posen S. The behavior of infused human placental alkaline phosphatase in human subjects. J. Lab. Clin. Med. 66:1965;493-507.
47. Komoda T., Sakagishi Y. The function of carbohydrate moiety and alteration of carbohydrate composition in human alkaline phosphatase isoenzymes. Biochim. Biophys. Acta. 523:1978;395-406.
48. Magnusson P., Farley J.R. Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif. Tissue Int. 71:2002;. [in press].
49. Nicolas V., Mohan S., Honda Y.et al. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone. Calcif. Tissue Int. 57:1995;206-212.